Nigel Ten Fleming Recognized by Cambridge Who's Who for Excellence in Pharmaceutical Technology
Mr. Fleming earned a degree, with highest honors, from The University of North Carolina at Chapel Hill and a Ph.D. from the University of Cambridge

MILL VALLEY, CA, August 5, 2011 /24-7PressRelease/ -- Nigel Ten Fleming, Founder, Chairman and Chief Executive Officer for G2B Pharma, has been recognized by Cambridge Who's Who for showing dedication, leadership and excellence in pharmaceutical technology.

As the CEO for a pharmaceutical company, Mr. Fleming is charged with several obligations, including execution of the company strategy. G2B Pharma is a private company that focuses primarily on the reformulation of off-patent drugs.

Mr. Fleming earned a B.A. degree, with highest honors, from The University of North Carolina at Chapel Hill, in addition to a Ph.D. in clinical biochemistry from the University of Cambridge. He intends to enter into retirement in the near future.

For more information about G2B Pharma, visit http://www.g2bpharma.com.

Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website